Penbrook Management’s Harvard Bioscience HBIO Stock Holding History

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-50,000	Closed	-$180K	–	100
2022 Q2	$180K	Hold	50,000	–	–	0.14%	100
2022 Q1	$311K	Hold	50,000	–	–	0.2%	89
2021 Q4	$353K	Hold	50,000	–	–	0.21%	83
2021 Q3	$349K	Hold	50,000	–	–	0.22%	90
2021 Q2	$417K	Buy	+50,000	New	+$417K	0.25%	85
2016 Q3	$364K	Hold	134,100	–	–	0.39%	76
2016 Q2	$383K	Sell	134,100 -1,850	-1%	-$5.28K	0.42%	75
2016 Q1	$410K	Hold	135,950	–	–	0.45%	72
2015 Q4	$471K	Buy	135,950 +6,000	+5%	+$20.8K	0.48%	71
2015 Q3	$492K	Hold	129,950	–	–	0.52%	70
2015 Q2	$741K	Sell	129,950 -285,100	-69%	-$1.63M	0.7%	59
2015 Q1	$2.42M	Sell	415,050 -16,900	-4%	-$98.3K	2.15%	5
2014 Q4	$2.45M	Hold	431,950	–	–	2.21%	5
2014 Q3	$1.77M	Sell	431,950 -2,800	-0.6%	-$11.5K	1.63%	11
2014 Q2	$1.98M	Sell	434,750 -678,962	-61%	-$3.09M	1.75%	12
2014 Q1	$5.26M	Buy	1,113,712 +553,706	+99%	+$2.61M	2.52%	3
2013 Q4	$2.63M	Buy	+560,006	New	+$2.63M	2.55%	5